Past performance is not indicative of future results. The value of fund units/shares can rise as well as fall and you may not get back the amount you invested. Funds with a risk level of 5-7 according to the fund’s key information document (KID) can both decrease and increase significantly in value. Fund information, including the KID, prospectus, and sustainability-related disclosures can be found at www.sebgroup.lu/funds.
The merger took effect on 21 April 2023 and is finalised.
The following funds, both Luxembourg-domiciled, were involved in the merger:
- SEB Fund 3 - SEB Medical Fund merged with SEB Concept Biotechnology
Now that the merger is effective, the SEB Fund 3 - SEB Medical Fund no longer exists. Customers who had investments in the SEB Fund 3 - SEB Medical Fund are encouraged to read the information about the merger that was published on this website on 7 March 2023.